Searle Celebrex Alzheimer's Trial To Finish By End Of January In U.K.
Executive Summary
A pilot study of Searle's nonsteroidal anti-inflammatory drug Celebrex (celecoxib) for Alzheimer's is slated to finish by the end of January, according to data in the U.K. Department of Health's National Research Register database.
You may also be interested in...
GSK Trial Registry Begins With Avandia; Includes 25 Unpublished Studies
GlaxoSmithKline's clinical trial registry for the diabetes drug Avandia includes five unpublished placebo-controlled trials
GSK Trial Registry Begins With Avandia; Includes 25 Unpublished Studies
GlaxoSmithKline's clinical trial registry for the diabetes drug Avandia includes five unpublished placebo-controlled trials
GSK Posts Paxil Pediatric Data On Website; Plans U.S. Clinical Trial Register
GlaxoSmithKline's off-the-shelf response to requests for information about off-label use of Paxil in pediatric patients notes that there are studies demonstrating efficacy of paroxetine in obsessive/compulsive disorder and social anxiety disorder